Ropivacaine mesylateCAS# 854056-07-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 854056-07-8 | SDF | Download SDF |
PubChem ID | 24784155 | Appearance | Powder |
Formula | C18H30N2O4S | M.Wt | 370.5 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide;methanesulfonic acid | ||
SMILES | CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.CS(=O)(=O)O | ||
Standard InChIKey | YPTSIOMXZOPKAF-RSAXXLAASA-N | ||
Standard InChI | InChI=1S/C17H26N2O.CH4O3S/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3;1-5(2,3)4/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20);1H3,(H,2,3,4)/t15-;/m0./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Ropivacaine mesylate Dilution Calculator
Ropivacaine mesylate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.6991 mL | 13.4953 mL | 26.9906 mL | 53.9811 mL | 67.4764 mL |
5 mM | 0.5398 mL | 2.6991 mL | 5.3981 mL | 10.7962 mL | 13.4953 mL |
10 mM | 0.2699 mL | 1.3495 mL | 2.6991 mL | 5.3981 mL | 6.7476 mL |
50 mM | 0.054 mL | 0.2699 mL | 0.5398 mL | 1.0796 mL | 1.3495 mL |
100 mM | 0.027 mL | 0.135 mL | 0.2699 mL | 0.5398 mL | 0.6748 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- (-)-Haplomyrfolin
Catalog No.:BCN3225
CAS No.:85404-48-4
- Norcaesalpinin E
Catalog No.:BCN7006
CAS No.:854038-96-3
- Dasatinib hydrochloride
Catalog No.:BCC1517
CAS No.:854001-07-3
- OGT 2115
Catalog No.:BCC7458
CAS No.:853929-59-6
- NVP-BAG956
Catalog No.:BCC1813
CAS No.:853910-02-8
- (+)-AJ 76 hydrochloride
Catalog No.:BCC6747
CAS No.:85378-82-1
- SKF 89976A hydrochloride
Catalog No.:BCC6930
CAS No.:85375-15-1
- 5,19-Epoxy-19R,25-dimethoxycucurbita-6,23-dien-3-ol
Catalog No.:BCN1328
CAS No.:85372-72-1
- 5,19-Epoxy-19S,25-dimethoxycucurbita-6,23-dien-3-ol
Catalog No.:BCN1329
CAS No.:85372-70-9
- SecinH3
Catalog No.:BCC7503
CAS No.:853625-60-2
- K03861
Catalog No.:BCC6537
CAS No.:853299-07-7
- Trichorabdal A
Catalog No.:BCN4404
CAS No.:85329-59-5
- Rilmenidine Phosphate
Catalog No.:BCC5637
CAS No.:85409-38-7
- S- (+)-Rolipram
Catalog No.:BCC2303
CAS No.:85416-73-5
- (R)-(-)-Rolipram
Catalog No.:BCC5429
CAS No.:85416-75-7
- Caffeic anhydride
Catalog No.:BCN3295
CAS No.:854237-32-4
- Ajugamarin chlorohydrin
Catalog No.:BCN3664
CAS No.:85447-27-4
- 4-Chlorotestosterone acetate
Catalog No.:BCC8705
CAS No.:855-19-6
- Eupatorin
Catalog No.:BCN4405
CAS No.:855-96-9
- PK 11195
Catalog No.:BCC6745
CAS No.:85532-75-8
- Safflor Yellow A
Catalog No.:BCN2408
CAS No.:85532-77-0
- NBI-74330
Catalog No.:BCC4111
CAS No.:855527-92-3
- Rhodionin
Catalog No.:BCN1248
CAS No.:85571-15-9
- Kurarinol
Catalog No.:BCN3447
CAS No.:855746-98-4
[Clinical effectiveness of ropivacaine mesylate in epidural anesthesia and postoperative analgesia].[Pubmed:15663236]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Dec;26(6):700-3.
OBJECTIVE: To compare the clinical effectiveness of Ropivacaine mesylate and ropivacaine hydrochloride in epidural anesthesia and postoperative analgesia. METHODS: Forty-four patients undergoing epidural anesthesia for intraperitoneal hysterectomy or hysteromyomectomy were randomly assigned to two equal groups. Group ropivacaine hydrochloride received 15 ml ropivacaine hydrochloride of 7.5 mg/ml in anesthetic and 2 mg/ml in postoperative analgesic subsequently while group Ropivacaine mesylate correspondingly received Ropivacaine mesylate of both 15 ml of 8.94 mg/ml and 2.374 mg/ml. RESULTS: No significant differences were found in the onset, extent, and duration of sensory and motor blockage, and also in the hemodynamic stability, when Ropivacaine mesylate was comparable with ropivacaine hydrochloride. No severe adverse events were observed in this study. CONCLUSION: Ropivacaine mesylate is an effective and safe alternative to ropivacaine hydrochloride in epidural anesthesia and postoperative analgesia.